Twice the output, half the runtime, and half the footprint of the UG 100® with greater flexibility and improved genomic ...
BALTIMORE--(BUSINESS WIRE)--Genseq, a Dublin-based, CAP-accredited laboratory providing a range of services for biopharma and clinical research, has adopted the science-aware™ lab informatics platform ...
The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue to witness sequencer throughput expansion with systems like the Illumina ...
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today announced an agreement with Genomics England to further collaborate on the Generation Study. Under the new contract, Revvity will now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results